Portfolio company
Loyal
United States · £35.5m raised
Raised
£35.5m
Latest stage
Series B
Rounds recorded
1
Backed by
5 investors
Sectors
About
This biotechnology firm develops pharmaceutical drugs to extend the healthy lifespan of companion dogs for pet owners and veterinary professionals.
SourceFunding history · 1
Similar companies
ScoutBio
The company develops monoclonal antibodies and gene therapies for pets to treat chronic diseases.
LEAH Labs
This company develops gene-edited cell therapies for dogs with cancer for use by veterinarians.
Rejuvenate Bio
The company develops gene therapies to treat age-related chronic diseases in humans and companion animals.
Elita Pet
This company develops a health management platform and stem cell banking services for dog owners to enable proactive and personalised preventative care.
Vital Bites
This company produces health supplements for service and therapy dogs to improve their well-being and longevity.
PetMedix
PetMedix develops species-specific monoclonal antibody therapeutics for companion animals to treat chronic and terminal diseases in dogs and cats.
FidoCure
The company provides genomic testing and AI-enabled personalised treatment recommendations for dogs with cancer to veterinarians and pet owners.
Elita Genetics
This company provides stem cell banking services and a health monitoring application for dog owners to manage their pets' long-term wellbeing.
